Title: Recurrent Malignant Phyllodes Tumour of the Breast with Liposarcomatous Differentiation: A Rare Case Report and Review Of Literature

Authors: Dr M Kumara Raghavendra Varma, Prof. Bhaskaran A, Dr Pavan B K, Dr Asadulla Baig

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i2.84

Abstract

INTRODUCTION

Phyllodes tumor of the breast usually is a biphasic fibroepithelial neoplasm. Malignant transform-ation is seen in 10 to 20 % of cases and manifests in the form of fibrosarcomatous differentiation and rarely heterologous sarcomatous elements. Liposarcomatous differentiation is a rare entity among phyllodes tumors.

Spindle cell carcinoma is an unusual neoplasm commonly observed in the oral cavity1 and the larynx2. However, on rare occasions it occurs in the breast3, 4. Primary pure breast sarcoma is a rare disease and constitutes 0.2–1.0% of all mammary malignancies5.

Primary pure breast sarcomas or advanced breast sarcomas are rare and mostly secondary to radiotherapy. Latter forms the majority of breast sarcomas. Reported 5-year survival rates for patients with breast sarcoma range from 40 to 91%6, 7, 8

 

Sarcomatous stromal elements, including angiosarcoma, leiomyosarcoma, and rhabdomy-osarcoma, are infrequent in malignant phyllodes tumors. Liposarcomas usually show stromal components of phyllodes tumors. Liposarcom-atous differentiation is confirmed by noting well differentiated, myxoid, round cell, and pleomorphic liposarcomatous elements. The finding of a malignant heterologous element places the tumor into a malignant category.

References

1.      Someren A, Karcioglu Z, Clairmont A Jr. Polypoid spindle cell carcinoma (pleomorphic carcinoma). Oral Surg 1976;42:474–89

2.      Randall G, Alonso W, Ogura J. Spindle cell carcinoma (pseudosarcoma) of the larynx. Arch Otolaryngol1975;101:63–6

3.      Kaufman MW, Marti JR, Gallager HS, Hoehn JL. Carcinoma of the breast with pseudosarcomatous metaplasia. Cancer 1984;53:1908–17

4.      Ellis IO, Bell J, Ronan JE, Elston CW, Blamey RW. Immunocytochemical investigation of intermediate filament proteins and epithelial membrane antigen in spindle cell tumours of the breast. J Pathol1988;154:157–65

5.      5.Haberthur F, Feichter GE, Torhorst JK: Sarcoma of the breast: what is the contribution of immunohistochemistry and flow cytometry? [German] Geburtshilfe Frauenheilkd 1993;53:811–813

6.      Pollard SG, Marks PV, Temple LN, Thompson HH:Breast sarcoma: aclinico-pathologic review of 25 cases. Cancer 1990;66:941–944

7.      7.Callery CD, Rosen PP, Kinne DW: Sarcoma of the breast: study of 32 patients with reappraisal of classification and therapy. Ann Surg 1985;201:527–532

8.      8. Johnstone PA, Pierce LJ, Merino MJ, Yang JC, Epstein AH, DeLaney TF: Primary soft tissue sarcomas of the breast: local-regional control with postoperative radiotherapy. Int J Radiat Oncol Biol Phys 1993;27:671–675.

Corresponding Author

Dr M Kumara Raghavendra Varma